Advances in artificial intelligence-based technologies for increasing the quality of medical products

被引:1
作者
Srivastava, Nidhi [1 ]
Verma, Sneha [2 ]
Singh, Anupama [1 ]
Shukla, Pranki [1 ]
Singh, Yashvardhan [1 ]
Oza, Ankit D. [3 ]
Kaur, Tanvir [7 ]
Chowdhury, Sohini [5 ]
Kapoor, Monit [6 ]
Yadav, Ajar Nath [4 ,8 ]
机构
[1] Maharishi Univ Informat Technol, Maharishi Sch Pharmaceut Sci, Lucknow 226013, Uttar Pradesh, India
[2] Maharishi Univ Informat & Technol, Maharishi Sch Sci & Humanities, Lucknow, Uttar Pradesh, India
[3] Parul Univ, Parul Inst Technol, Dept Mech Engn, Vadodara, Gujarat, India
[4] Eternal Univ, Dr Khem Singh Gill Akal Coll Agr, Dept Genet Plant Breeding & Biotechnol, Sirmour, Himachal Prades, India
[5] Chitkara Univ, Chitkara Ctr Res & Dev, Baddi, Himachal Prades, India
[6] Chitkara Univ, Chitkara Univ Inst Engn & Technol, Ctr Res Impact & Outcome, Rajpura, Punjab, India
[7] Graph Era Deemed Be Univ, Dept Biotechnol, Dehra Dun, Uttarakhand, India
[8] Chandigarh Univ, Univ Ctr Res & Dev, Mohali, Punjab, India
关键词
Artificial intelligence; Computational medicines; Drug development; Healthcare industry; Machine learning; DRUG DISCOVERY; HEALTH-CARE; DISEASE; DESIGN; OPTIMIZATION; PREDICTION; LIBRARIES; STRATEGY; NETWORK; SUPPORT;
D O I
10.1007/s40199-024-00548-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Artificial intelligence (AI) is a technology that combines machine learning (ML) and deep learning. It has numerous usages in the domains of medicine and other sciences. Artificial intelligence can forecast the behavior of a drug's target protein and predict its desired physicochemical qualities. AI's potential to enhance healthcare services offerings formerly unheard-of opportunities for cost reserves, enhanced overall clinical and patient outcomes. The recent development of research in the biomedical field, encompassing fields such as genomics, computational medicine, AI, and algorithms for learning, has led to the demand for novel technology, a fresh workforce, and new standards of practice set the stage for the revolution in healthcare. By connecting these health statistics with cutting-edge AI technologies, precise insights into patient treatment can be obtained. Moreover, AI can aid in the search for new drugs by foretelling the target protein's two-dimensional structure. In the current review, an overview of the latest AI-based technologies and how they may be employed to reduce product development time to market and snowballing product quality, cost-effectiveness, as well as security throughout the manufacturing process is detailed.
引用
收藏
页数:21
相关论文
共 103 条
  • [1] Achilleos E.C., 2006, Pharmaceutical Engineering, V26, P34
  • [2] Concern about security and privacy, and perceived control over collection and use of health information are related to withholding of health information from healthcare providers
    Agaku, Israel T.
    Adisa, Akinyele O.
    Ayo-Yusuf, Olalekan A.
    Connolly, Gregory N.
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2014, 21 (02) : 374 - 378
  • [3] Heart rate variability features from nonlinear cardiac dynamics in identification of diabetes using artificial neural network and support vector machine
    Aggarwal, Yogender
    Das, Joyani
    Mazumder, Papiya Mitra
    Kumar, Rohit
    Sinha, Rakesh Kumar
    [J]. BIOCYBERNETICS AND BIOMEDICAL ENGINEERING, 2020, 40 (03) : 1002 - 1009
  • [4] Agrawal P., 2018, J Pharmacovigil, V6, P1000, DOI [10.4172/2329-6887.1000e173, DOI 10.4172/2329-6887.1000E173]
  • [5] Ali M., 2019, Telemed Technol, P139, DOI [10.1016/B978-0-12-816948-3.00009-X, DOI 10.1016/B978-0-12-816948-3.00009-X, 10.1016/b978-0-12-816948-3.00009-x]
  • [6] End-to-End Differentiable Learning of Protein Structure
    AlQuraishi, Mohammed
    [J]. CELL SYSTEMS, 2019, 8 (04) : 292 - +
  • [7] Using artificial intelligence methods to speed up drug discovery
    Alvarez-Machancoses, Oscar
    Luis Fernandez-Martinez, Juan
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (08) : 769 - 777
  • [8] Avdagic Zikrija, 2009, Summit Transl Bioinform, V2009, P1
  • [9] Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming
    Barmpalexis, Panagiotis
    Kachrimanis, Kyriakos
    Georgarakis, Emanouil
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 77 (01) : 122 - 131
  • [10] Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
    Bender, Andreas
    Cortes-Ciriano, Isidro
    [J]. DRUG DISCOVERY TODAY, 2020, 26 (02) : 511 - 524